• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Anti-Aging
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management

Top 3 challenges facing dermatologists


We asked you what your key challenges have been this year. These are your top-of-mind concerns.

We asked you what your key challenges have been this year. These are your top-of-mind concerns:

  • Preparing for merit-based incentive payment system and pay for performance programs

  • Prescription drug costs

  • Reimbursement

Read more about what your peers are saying about some of these topics:

Superior pay for non-performance model threatens dermatology, society

What would happen to society if people were paid more for doing less? Would people work harder and harder to get paid less or do less and less to get paid more? I think this question demands a large, properly powered, cross-sectional, multivariate, multi-generational, prospective, case-controlled study.

The tale of the $220 tube of clobetasol cream

The economic realities of increased prices for medications strike at the heart of the services that dermatologists provide for patients.  If we can no longer use medications that work best, we may revert to second-rate status medically and only marginally improve the lives of the people we treat. How did we get to this state of affairs?

Dermatologists view MIPS with trepidation

MIPS will replace the Physician Quality Reporting System (PQRS) and CMS will adjust Medicare payments to most physicians either up or down by as much as 9% depending on how well they score in four performance categories. One expert shares insight based on a recent article published in JAMA Forum.



Related Videos
© 2024 MJH Life Sciences

All rights reserved.